Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Kyras Therapeutics

Kyras Therapeutics
2015 FOUNDED
OOB STATUS
Out of Business LATEST DEAL TYPE
Description

Developer of drugs designed to cure cancer and other developmental disorders. The company's drugs address currently incurable cancers and developmental disorders caused by RAS gene mutations, enabling healthcare providers to cure their patients.

Website
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 430 East 29th Street
  • Suite 1005
  • New York, NY 10016
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Kyras Therapeutics’s full profile, request a free trial.

Kyras Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-Apr-2018 000 Completed Out of Business
3. Grant 16-Nov-2017 000 000 Completed Generating Revenue
2. Early Stage VC (Series A) 10-Dec-2015 $5M $5M 0000 Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Kyras Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 0,000,000 00.000000 00.00 00 00 00 00 00.000
To view this company’s complete Cap Table, request access »

Kyras Therapeutics Executive Team (3)

Name Title Board
Seat
Contact
Info
Joseph Vacca Ph.D Chief Scientific Officer
Brent Stockwell Ph.D Co-Founder, Board Member & Advisor
Carlo Rizzuto Ph.D Co-Founder, Board Member & Chief Executive Officer

Kyras Therapeutics Board Members (3)

Name Representing Role Since Contact
Info
Bradley Bolzon Ph.D Versant Venture Management Board Member 000 0000
Brent Stockwell Ph.D Kyras Therapeutics Co-Founder, Board Member & Advisor 000 0000
Carlo Rizzuto Ph.D Self Co-Founder, Board Member & Chief Executive Officer 000 0000